For losartan, initial peaks occurred from July 2015 to May 2016, >2 years before the recall, with later peaks in July 2018 and September 2019 (Figure III in the Data Supplement). However, we observed spikes at other times before and after the recall dates. Related news for the detection of impurities in sartan-containing products was also previously issued by. NHS regional teams are asked to forward this to relevant clinics, general practitioners and community pharmacists. As a result of this investigation, formulations containing losartan and losartan with hydrochlorothiazide were also recalled from the market however, it should be noted that some products were recalled voluntarily by manufacturers just after the first signals from the market. For irbesartan, the number of reports increased in October and November 2018. Regarding impurities in valsartan, a public announcement was issued on, and letters to inform local healthcare professionals were issued by the Department of Health (DH) on, , and. Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Company contacts for further informationįor stock control enquiries and medical information enquiries, please contact Accord Customer Services on 0800 373573.įor medical information enquiries please contact Accord Medical Information Department on 01271 385257. 6 On March 25, 2019, yet another pharmaceutical company issued a recall of 40 repackaged lots of losartan tablets USP 25 mg, 50 mg, and 100 mg. 2018 silverado 1500 lug nut size, How to bring a synthetic wig back to life. We will continue to monitor the situation in the UK and consider what actions are necessary to protect public health. Losartan: In early November 2018, another company recalled its losartan potassium-hydrochlorothiazide (HCTZ) product after discovering that it was contaminated with NDEA. recall, How to sink a sub Military hobbies and the toy soldier experience. The MHRA continues to thoroughly investigate the issue alongside the European Medicines Agency (EMA) and the European Directorate for the Quality of Medicines (EDQM). In case of local supply issues, patients should be advised to speak to their doctor to discuss alternative treatments. We do not anticipate any shortages of Losartan Potassium containing products. A treatment review is not necessary until the next routine appointment. If you receive queries about this issue from patients, advise them to continue taking their medication as the health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. Stop supplying the batches listed above immediately. Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023 Batch number Accord Healthcare Limited Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022 Batch number
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |